Table 4.
Clinical characterization from Visit 0 to Visit 1 (all subjects, n = 234)
| Characteristics | Visit 0 | Visit 1 | p a value |
|---|---|---|---|
| Daily dose of inhaled budesonide equivalent in the last 3 months (μ ± SD) | b | 813.3 (±247.5) | - |
| Use of long acting B2 agonists associated to inhaled corticosteroids n(%) | b | 200 (86) | - |
| Any oral corticosteroid requirement in the year before the visit n(%) | 152 (65) | 86 (37) | <0.01 |
| Number of emergency room visits due to asthma in the year before M(p25-p75) | 5 (2–15) | 0 (0–2) | <0.01 |
| Proportion of patients that need emergency room visits due to asthma in the year before n(%) | 172 (74) | 113 (48) | <0.01 |
| Proportion of patients that need ICU admission due to asthma in the year before n(%) | 19 (9) | 2 (1) | <0.01 |
Note: aMcNemar and Wilcoxon Tests. bSubjects were not using regular inhaled corticosteroids before Visit 1. M(p 25 -p 75 ) median and interquartile range